What BPC-157 is
BPC-157 is a synthetic chain of 15 amino acids, based on a sequence described in human gastric juice. It's mainly discussed for tendons, ligaments, muscles and the gut lining.
It has attracted a lot of attention online. The research behind that attention is much earlier-stage than the claims often suggest.
How it's thought to work
Laboratory and animal research points to several possible effects:
- Formation of new blood vessels, which matters in tissues with poor blood supply
- Activity of fibroblasts, the cells that produce collagen
- Better organisation of collagen during healing
- Changes in inflammatory signalling
These are possible mechanisms from early research. They don't show that BPC-157 produces the same benefits in people.
What human evidence exists
A 2025 systematic review in orthopaedic sports medicine found one published human study. It involved 12 people with chronic knee pain, and 7 reported improvement lasting more than 6 months after one joint injection.
That study was retrospective and had no comparison group, so it can't show whether BPC-157 caused the improvement. The review also found one registered phase I trial, with no results available.
The authors concluded that the evidence is early and preclinical, and can't yet support clinical guidelines.
Is it safe?
Human safety is still unknown. Animal studies reported no acute toxicity, but none assessed adverse events beyond 6 weeks.
Ambrosia's product information lists these reasons not to use BPC-157:
- Active cancer or a history of cancer
- Pregnancy or breastfeeding
- Hypersensitivity to BPC-157
Tell your doctor if you take blood thinners, antiplatelets or other growth-promoting treatments. Possible side effects include injection-site redness, swelling or bruising, nausea and light-headedness.
What results can you expect?
There's no reliable human evidence for a week-by-week recovery timeline. Injuries vary widely, and many improve with time and rehabilitation alone.
Agree with your doctor how you'll judge progress, such as pain, range of movement or return to activity. BPC-157 should sit alongside physiotherapy, not replace it.
How Ambrosia dispenses it
- BPC-157 Cartridge: 14 mg in 2,4 ml, usually injected once a day
- Wolverine Stack Cartridge: BPC-157 14 mg with TB-500 14 mg in 2,6 ml
- Glow Stack Cartridge: BPC-157 14 mg, TB-500 14 mg and GHK-Cu 70 mg in 2,4 ml
Your doctor decides whether it suits you and sets your dose. Every Ambrosia treatment requires a prescription.
Why sourcing matters
BPC-157 is widely sold online, and the HSS Journal review flags contamination and unregulated manufacturing as risks. Know who made your product and who is overseeing your treatment.
If you compete in sport
BPC-157 is on the World Anti-Doping Agency's Prohibited List and is banned at all times. Don't use it if you compete under an anti-doping code.
This article is for educational purposes only and is not medical advice.


